Choroideremia Treatment Market Size

Choroideremia Treatment Market size is estimated to reach USD 33 billion by the end of 2036, expanding around 5% CAGR during the forecast period i.e., 2024-2036. In the year 2023, the industry size of choroideremia treatment was over USD 9 billion.

 The growth of this market can be ascribed to the increasing prevalence of choroideremia all across the globe. 1 in 50,000 to 100,000 people in the United States has choroideremia according to the Centers for Disease Control and Prevention.

Due to the delay in diagnosis and treatment of patients with choroideremia, COVID-19 is likely to have an important effect on the therapeutic market for choroideremia. Anyhow, the result will be short-term and post-COVID-19 pandemic, the choroideremia treatment market will show a significant surge owing to an increase in treatment adoption.